1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
MEDIPOST Co., Ltd.

MEDIPOST Co., Ltd.

078160.KQ
MEDIPOST Co., Ltd.KR flagKOSDAQ
9,010.00
KRW
-150.00
- -
352.16BMarket Cap

Total Valuation

MEDIPOST Co., Ltd. carries a market capitalization of 352.16B, placing it among publicly traded companies globally. Its enterprise value stands at 679.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap352.16B
Enterprise Value679.28B

Share Statistics

MEDIPOST Co., Ltd. currently has 39.09M shares outstanding.

Shares Outstanding39.09M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 10.04, and the price-to-book ratio stands at -4.21.

PE RatioN/A
PS Ratio10.04
PB Ratio-4.21
P/TBV Ratio3.12
P/FCF Ratio-15.00
P/OCF Ratio-13.68

Enterprise Valuation

EV / Sales9.19
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

MEDIPOST Co., Ltd. maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 64.07, indicating elevated leverage, while an interest coverage ratio of -12.16 demonstrates limited ability to service its debt obligations.

Current Ratio1.08
Quick Ratio0.87
Debt / Equity64.07
Debt / EBITDA-2.17
Interest Coverage-12.16

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-16.30
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.42

Taxes

Income Tax747.56M
Effective Tax RateN/A

Stock Price Statistics

MEDIPOST Co., Ltd.'s stock has declined approximately -19.26523% over the past 52 weeks. The 50-day moving average sits at 15,427.20, while the 200-day moving average is 17,896.05.

Beta (5Y)N/A
52-Week Price Change-19.26523%
50-Day Moving Average15,427.20
200-Day Moving Average17,896.05
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, MEDIPOST Co., Ltd. generated 73.90B in revenue and converted that into -79.57B in net income, yielding earnings per share of -2,292.28. EBITDA reached -71.17B, while operating income came in at -71.17B.

Revenue73.90B
Gross Profit46.90B
Operating Income-71.17B
Pretax Income-79.44B
Net Income-79.57B
EBITDA-71.17B
EBIT-71.17B
Earnings Per Share (EPS)-2,292.28

Balance Sheet

MEDIPOST Co., Ltd. holds 217.66B in cash and equivalents against 154.58B in total debt, resulting in a net debt position of 50.43B. Total book value stands at -176.22B, with working capital of 20.04B providing operational flexibility.

Cash & Cash Equivalents217.66B
Total Debt154.58B
Net Debt50.43B
Equity (Book Value)-176.22B
Book Value Per Share-5,037.68
Working Capital20.04B

Cash Flow

MEDIPOST Co., Ltd. produced -54.22B in operating cash flow over the past twelve months. After subtracting -4.78B in capital expenditures, free cash flow totaled -59.00B - equivalent to -1,686.51 per share.

Operating Cash Flow-54.22B
Capital Expenditures-4.78B
Free Cash Flow-59.00B
FCF Per Share-1,686.51

Margins

MEDIPOST Co., Ltd. operates with a gross margin of 63.46, reflecting its pricing power and cost economics. The operating margin of -96.31 and net profit margin of -107.68 provide insight into operational efficiency.

Gross Margin63.46
Operating Margin-96.31
Pretax Margin-107.50
Profit Margin-107.68
EBITDA Margin-96.31

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-27.38
FCF Yield-6.67

Stock Splits

MEDIPOST Co., Ltd.'s most recent stock split took place on September 19, 2023 with a 1000:1137 split ratio.

Last Split Date9/19/2023
Split Ratio1000:1137

Scores

MEDIPOST Co., Ltd. posts an Altman Z-Score of 0.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.61